Empirical Ventures has enhanced its financial backing with a £10 million commitment from the British Business Bank, aiming to foster innovation among UK scientists. This support aligns with their mission to fund venture scientists equipped to convert scientific knowledge into lucrative business ventures. The infusion of capital underscores the organization’s commitment to transforming research into sustainable enterprises by bridging the funding gap for scientific entrepreneurs outside the capital.
In prior commitments, Empirical Ventures has consistently sought out innovative partnerships that align with its goals of supporting deeptech and life sciences within the UK. The new fund appears to reinforce previous strategies by providing more significant resources to its identified ‘Venture Scientists.’ These efforts highlight the persistent challenge within the funding landscape: securing investment for pioneering science-led businesses that might traditionally struggle to find financial support.
What is the British Business Bank’s Role in Science and Tech Funding?
The British Business Bank’s involvement through its Regional Angels Programme plays a crucial role in distributing funds more evenly across geographical locations, rather than concentrating resources in London. This strategy is crafted to alleviate long-standing investment disparities and broaden opportunities for regional innovators. Such support is seen as pivotal in allowing Empirical Ventures the capability to back scientists from diverse UK regions, enabling the growth of high-skilled employment through scientific initiatives.
How Does Empirical Ventures Enhance Opportunities for Scientists?
By offering financial resources, Empirical Ventures is facilitating the transition of scientists from laboratory research to real-world technological advancements. Their model merges patient capital with specific investment schemes such as SEIS & EIS Fund. This support system is integral for aspiring scientists tasked with solving complex problems and innovating in areas like new energy technologies and advanced materials.
Mark Barry, Senior Investment Director at British Business Bank, highlighted the partnership’s value, saying,
“We are delighted to expand our commitment to Empirical Ventures. Their team has identified a powerful untapped resource in the UK economy: the ‘Venture Scientist.’”
This cooperation is portrayed as essential support for turning UK-based scientific research into globally recognized companies.
Empirical Ventures Co-Founder, Dr. Johnathan Matlock, acknowledged that the additional £10 million funding sharpens their focus on scientific founders derailed by conventional investor scepticism. He stated,
“This £10 million commitment from the British Business Bank allows us to back these Venture Scientists with the conviction they deserve.”
The deliberate focus is on facilitating the conversion of scientific prowess into pioneering enterprises across the UK.
Empirical Ventures is playing a crucial role in invigorating the UK’s innovative capabilities, aligning with the 2026 Modern Industrial Strategy. By aligning funding practices with the unique needs of scientific founders, the organization offers a pathway for cutting-edge research to transition seamlessly into industry-leading businesses.
Summary of the initiative highlights the integration of specialized investment formats such as SEIS and EIS with regional empowerment strategies. Future prospects hinge on sustaining this finance model, potentially setting precedents for further worldwide adoption in the funding of science-led businesses.
